Invention Grant
- Patent Title: Thiazolopyrimidinone derivatives as PI3 kinase inhibitors
- Patent Title (中): 噻唑并嘧啶酮衍生物作为PI3激酶抑制剂
-
Application No.: US13319375Application Date: 2010-05-20
-
Publication No.: US08410095B2Publication Date: 2013-04-02
- Inventor: Hong Lin , Juan I. Luengo , Ralph A. Rivero , Mark James Schulz , Ren Xie , Jin Zeng
- Applicant: Hong Lin , Juan I. Luengo , Ralph A. Rivero , Mark James Schulz , Ren Xie , Jin Zeng
- Applicant Address: US PA Philadelphia
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US PA Philadelphia
- Agent J. Scott Young
- International Application: PCT/US2010/035535 WO 20100520
- International Announcement: WO2010/135504 WO 20101125
- Main IPC: A61K31/535
- IPC: A61K31/535 ; C07D413/14
Abstract:
This invention relates to novel compounds of formula (I): and derivatives thereof useful for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3′ OH kinase family (hereinafter PI3 kinases), suitably, PI3Kα, PI3Kδ, PI3Kβ, and/or PI3Kγ.
Public/Granted literature
- US20120053147A1 THIAZOLOPYRIMIDINONE DERIVATIVES AS PI3 KINASE INHIBITORS Public/Granted day:2012-03-01
Information query
